ApoJ-Glyc

APOJlipoprotein

Clusterin (ApoJ) glycoprotein variant released during myocardial ischemia and endothelial injury.

Pathway placement

Cascade stepMyocardial injury (shared endpoint)

Confidencemedium

RationaleGlycosylated apolipoprotein variant; myocardial ischemia biomarker.

Also acts inEndothelial activation/erosion

Druggability

Not assessed (no mapped human gene target).

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.

Specimen

Serum or plasma

Collection tube

Serum separator (gold/red-top, SST)

Method / principle

Immunoturbidimetric/nephelometric; or NMR/ultracentrifugation for subfractions

Reagent / substrate

Anti-apolipoprotein antibody-latex; or NMR profile

Platform

Automated analyzer / NMR

Turnaround · availability

Routine–send-out · Variable